We are live on
!
Find out more
Grantham, Mayo, Van Otterloo & Co (GMO) Portfolio holdings
AUM
$39.1B
1-Year Est. Return
28.69%
This Fund
S&P 500
This Quarter
Est. Return
+8.09%
1 Year Est. Return
+28.69%
3 Year Est. Return
+71.15%
5 Year Est. Return
+97.93%
10 Year Est. Return
+429.41%
AUM
$19.7B
AUM Growth
+$887M
(+4.7%)
Cap. Flow
-$108M
Cap. Flow
% of AUM
-0.55%
Top 10 Holdings %
Top 10 Hldgs %
26.71%
Holding
793
New
86
Increased
241
Reduced
343
Closed
100
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sunrun
RUN
|
+$105M |
| 2 |
Darling Ingredients
DAR
|
+$76.9M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$74.5M |
| 4 |
LTHM
Livent Corporation
LTHM
|
+$67.8M |
| 5 |
Ameresco
AMRC
|
+$51.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$122M |
| 2 |
American Express
AXP
|
+$58.4M |
| 3 |
BorgWarner
BWA
|
+$51.7M |
| 4 |
AGCO
AGCO
|
+$45.3M |
| 5 |
RFP
Resolute Forest Products Inc.
RFP
|
+$41.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.23% |
| 2 | Healthcare | 18.26% |
| 3 | Financials | 9.79% |
| 4 | Consumer Discretionary | 8.96% |
| 5 | Communication Services | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
NGM
676
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
| $107K | ﹤0.01% |
+26,300
| New | +$122K |
|
677
Community Health Systems
CYH
$412M
| $100K | ﹤0.01% |
+20,400
| New | +$107K |
|
|
AZRE
678
DELISTED
Azure Power Global Limited
AZRE
| $98.4K | ﹤0.01% |
39,500
| – | – |
|
679
SelectQuote
SLQT
$133M
| $88.1K | ﹤0.01% |
+40,600
| New | +$65.5K |
|
|
CURO
680
DELISTED
CURO Group Holdings Corp.
CURO
| $87.1K | ﹤0.01% |
50,371
-12,100
| -19% | -$39.3K |
|
681
Alibaba
BABA
$305B
| $84.7K | ﹤0.01% |
829
-17,932
| -96% | -$1.8M |
|
|
FSP
682
Franklin Street Properties
FSP
$48.1M
| $80.4K | ﹤0.01% |
+51,200
| New | +$129K |
|
683
CarParts.com
PRTS
$44.2M
| $67.3K | ﹤0.01% |
+1,260
| New | +$79.8K |
|
684
DHI Group
DHX
$175M
| $66.7K | ﹤0.01% |
17,200
-6,400
| -27% | -$30.4K |
|
685
Lincoln Educational Services
LINC
$1.37B
| $62.8K | ﹤0.01% |
11,100
-11,100
| -50% | -$67.4K |
|
686
Ambev
ABEV
$47.1B
| $57K | ﹤0.01% |
20,200
-88,900
| -81% | -$233K |
|
|
OSG
687
DELISTED
Overseas Shipholding Group Inc.
OSG
| $56.9K | ﹤0.01% |
+14,600
| New | +$52.6K |
|
688
Five Point Holdings
FPH
$368M
| $56.8K | ﹤0.01% |
24,081
| – | – |
|
689
LifeVantage
LFVN
$83M
| $37.4K | ﹤0.01% |
10,414
| – | – |
|
690
Amneal Pharmaceuticals
AMRX
$6.02B
| $32.1K | ﹤0.01% |
+23,100
| New | +$46K |
|
|
TSP
691
DELISTED
TuSimple Holdings Inc. Class A Common Stock
TSP
| $30.9K | ﹤0.01% |
+21,000
| New | +$39.7K |
|
|
NBIS
692
Nebius Group N.V.
NBIS
$54B
| $20.8K | ﹤0.01% |
109,700
+26,500
| +32% | +$5.02K |
|
693
Nuvation Bio
NUVB
$2.14B
| $19.6K | ﹤0.01% |
+11,800
| New | +$23.9K |
|
694
Asbury Automotive
ABG
$4.24B
| – | – |
-2,700
| Closed | -$484K |
|
695
American International
AIG
$41.8B
| – | – |
-53,800
| Closed | -$3.4M |
|
696
Applied Industrial Technologies
AIT
$13B
| – | – |
-14,071
| Closed | -$1.77M |
|
697
Albemarle
ALB
$14B
| – | – |
-6,262
| Closed | -$1.36M |
|
698
Advanced Micro Devices
AMD
$790B
| – | – |
-8,400
| Closed | -$544K |
|
699
Applovin
APP
$136B
| – | – |
-243,700
| Closed | -$2.57M |
|
700
Aptiv
APTV
$12.1B
| – | – |
-19,100
| Closed | -$1.78M |
|
Similar funds
HF
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2023 Portfolio in Review
As of Q1 2023, Grantham, Mayo, Van Otterloo & Co (GMO) held 793 positions worth $19.7B, up 4.7% from $18.8B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Q1 2023 filing shows 86 new, 241 increased, 343 reduced and 100 closed positions. Its largest new stake was Ovintiv: 661,733 shares worth $23.9M. The largest sale was US Bancorp, an estimated $122M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s largest Q1 2023 buy was Ovintiv: 661,733 shares worth $23.9M.
- Grantham, Mayo, Van Otterloo & Co (GMO) added most to Sunrun in Q1 2023, an estimated $105M increase.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s biggest Q1 2023 reduction was US Bancorp, cutting an estimated $122M.
- Grantham, Mayo, Van Otterloo & Co (GMO) fully exited Resolute Forest Products Inc. in Q1 2023, selling an estimated $41.2M.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s ten largest holdings make up 27% of its $19.7B portfolio in Q1 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO) opened 86 new positions and closed 100 in Q1 2023.
- Grantham, Mayo, Van Otterloo & Co (GMO)'s portfolio value rose 4.7% quarter-over-quarter to $19.7B.
Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2023, filed 12 May 2023.